Sharing Mayo Clinic

Stories from patients, family, friends and Mayo Clinic staff

Share this:

Mar 24, 2010 · Leave a Reply

Waldenström Macroglobulinemia: Integrated Treatment and Research at Mayo Clinic

By Lee Aase, Director, Mayo Clinic Social Media Network @LeeAase

Earl Nolting was diagnosed with Waldenström Macroglobulinemia (WM) in 2000. WM is a rare disorder involving enlargement of the liver and spleen associated with anemia, nose bleeding, and an abnormal blood protein.

After his diagnosis, Earl joined a WM support group, which led him to Mayo Clinic. At his very first meeting, people were talking about Mayo Clinic and the research and treatment they were developing for this relatively rare disease.

Mr. Nolting shares his experience as a WM patient at Mayo Clinic in the video below.

For more information about WM at Mayo Clinic, watch interviews with three experts in Waldenström Macroglobulinemia — Morie Gertz, M.D., Steve Ansell, M.D., and Craig Reeder, M.D. They describe basic and translational research, clinical trials, new therapies and the integrated care available to WM patients at Mayo Clinic.

Add to FacebookAdd to DiggAdd to Del.icio.usAdd to StumbleuponAdd to RedditAdd to BlinklistAdd to TwitterAdd to TechnoratiAdd to Yahoo BuzzAdd to Newsvine

Tags: Dr. Craig Reeder, Dr. Morie Gertz, Dr. Steve Ansell, Hematology, research, Waldenstrom Macroglobulinemia

Please login or become a member to post a comment.

Contact Us · Privacy Policy